Attovia Therapeutics
PublicAttovia Therapeutics is now publicly traded
The data on this page reflects Attovia Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series C
Apr 15, 2025
Total Funding Raised
$315M
Company Overview
Attovia Therapeutics is a biotechnology company that develops precision biologics and multispecific therapeutics for immune-mediated diseases and oncology.
Sector
Biotech
Verticals
Life Sciences, Oncology
AI Layer
Non-AI
Keywords
Attovia Therapeutics Comparables
Compare Attovia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santa Ana Bio | 79% | |
| Bambusa Therapeutics | 79% | |
| Alumis | 77% |
Attovia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 15, 2025 | ||||
| Series B | May 9, 2024 | ||||
| Series A | Feb 8, 2024 | ||||
| Series A | Jun 20, 2023 |
Key People
Founding team and executive leadership
Attovia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series C, Series B |
| Redmile Group | Series B |
| Mirae Asset | Series C |
| Cormorant Asset Management | Series C, Series B |
| Vida Ventures | Series C |
| Deep Track Capital | Series C |
| Frazier Life Sciences | Series C, Series B, Series A |
Recent news
Latest coverage and updates
- attends_eventSep 28, 2026
Attovia will attend event EADV 2026 on Sep 30th '26.
- attends_eventSep 28, 2026
Attovia plans to present new data at the Fall Clinical Dermatology Conference 2026 in Nevada in Oct '26
- receives_financingAug 6, 2026
Attovia Therapeutics, Inc. received financing of $332M in IPO on Aug 5th '26.
- receives_financingAug 4, 2026
Attovia Therapeutics, Inc. received financing of $289M in IPO on Mar 31st '26.
- is_developingAug 4, 2026
Attovia Therapeutics, Inc. is developing biologic therapies for immune-mediated diseases on Jul 1st '23.
Attovia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access